Reach out about this clinical trial
Contact Usor call 602-258-2863
CONDITION(S): Glioblastoma, glioma, GBM - TRIAL: A Phase 0/2 Study of LY3214996 (ERK Inhibitor) in Combination With Abemaciclib (CDK4 and 6 Inhibitor) in Recurrent Glioblastoma Participants Scheduled for Resection to Evaluate Central Nervous System (CNS) Penetration